Heparin-Induced Thrombocytopenia Diagnosis and Management
Diagnostic Approach
- The American College of Chest Physicians recommends calculating the 4Ts score to evaluate thrombocytopenia severity, timing of platelet fall, thrombosis or other sequelae, and other causes of thrombocytopenia, with a low score (0-3 points) indicating a HIT probability of 0-3% and no further testing needed 1, 3, 4
- A intermediate score (4-5 points) or high score (6-8 points) should proceed with laboratory testing, with the American College of Chest Physicians recommending discontinuation of all heparin immediately as thrombosis risk is approximately 5% per day without treatment 1, 3
- The initial laboratory testing should include an immunoassay (ELISA) as the first-line screening test, which detects anti-PF4/heparin antibodies with high sensitivity, according to the American College of Chest Physicians 1, 4
Confirmatory Testing
- If ELISA is positive, the American College of Chest Physicians recommends ordering a serotonin release assay (SRA) for confirmation, which detects only platelet-activating antibodies capable of causing clinical HIT 1, 2, 3, 4
- The SRA has a sensitivity of 97.2% and high specificity for HIT, and is considered the gold standard confirmatory test for HIT by the American College of Chest Physicians 1, 2, 3
Clinical Pitfalls
- The American College of Chest Physicians notes that 24-61% of patients with high 4Ts scores do not actually have HIT, and that ELISAs detect antibody seroconversion but cannot distinguish pathogenic from non-pathogenic antibodies 1, 2, 3
- Functional assays like SRA are essential for confirmation before prolonged alternative anticoagulation, according to the American College of Chest Physicians 1, 4
Treatment
- The American College of Chest Physicians recommends immediate initiation of alternative anticoagulation upon clinical suspicion with intermediate or high 4Ts score, without waiting for SRA results 1, 3, 4
- A positive SRA in a patient with clinical HIT strongly supports continued alternative anticoagulation, according to the American College of Chest Physicians 4